Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,461 | -5,533 | -41,852 | -35,712 | -24,237 |
| Depreciation Amortization | 221 | 94 | 108 | 70 | 44 |
| Accounts receivable | 75 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -2,467 | -4,005 | 816 | 5,596 | 1,829 |
| Other Working Capital | 57,204 | -5,572 | 3,396 | 3,872 | 3,976 |
| Other Operating Activity | 5,253 | 5,322 | 2,186 | -3,501 | -712 |
| Operating Cash Flow | $44,825 | $-9,694 | $-35,346 | $-29,675 | $-19,100 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 22,441 | 13,186 | 17,584 | 12,710 | 1,712 |
| PPE Investments | -254 | -56 | -821 | -335 | -200 |
| Investing Cash Flow | $22,187 | $13,130 | $16,763 | $12,375 | $1,512 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | 5,000 | 1,977 | 1,977 | N/A |
| Debt Repayment | N/A | N/A | -1,333 | -1,333 | -1,000 |
| Common Stock Issued | 2 | N/A | 23,611 | 23,611 | 23,598 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 11 |
| Financing Cash Flow | $5,002 | $5,000 | $24,255 | $24,255 | $22,609 |
| Exchange Rate Effect | -49 | -113 | -6 | -17 | -10 |
| Beginning Cash Position | 16,509 | 16,509 | 10,843 | 10,843 | 10,843 |
| End Cash Position | 88,474 | 24,832 | 16,509 | 17,781 | 15,854 |
| Net Cash Flow | $71,965 | $8,323 | $5,666 | $6,938 | $5,011 |
| Free Cash Flow | |||||
| Operating Cash Flow | 44,825 | -9,694 | -35,346 | -29,675 | -19,100 |
| Capital Expenditure | -254 | -56 | -821 | -335 | -200 |
| Free Cash Flow | 44,571 | -9,750 | -36,167 | -30,010 | -19,300 |